Association Between Serum Ferritin Levels and Insulin Resistance in Nondiabetic Brazilians
Keywords:Ferritin, Insulin Resistance, Metabolic Syndrome
Background: Previous studies have pointed to a relation between high serum levels of ferritin and insulin resistance.
Objective: To analyze the association between the serum concentrations of ferritin and resistance to insulin, and metabolism of glucose, in nondiabetic persons.
Method: A transversal study was undertaken with 151 nondiabetic persons in SÃ£o LuÃs, Brazil, in 2013. The following biochemical variables were analyzed: glycated hemoglobin, fasting glycemia, fasting insulin, total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, serum ferritin and high-sensitivity C reactive proteins (hs-CRP).
Results: Among the participants with high levels of ferritin, approximately 20% and 40%, respectively, also had raised LDL-C (p=0.040) and hs-CRP (p=0.021). Prediabetes (p=0.016) and insulin resistance (p=0.026) had a statistically significant association with high levels of ferritin. The participants with raised ferritin also had double the probability of having raised hs-CRP (odds ratio = 2.29 / p=0.036).
Conclusion: There was a statistically significant association between prediabetes and insulin resistance and raised levels of ferritin.Â
Huang J, Jones D, Luo B, Sanderson M, Soto J, Cooksey RC, et al. Iron overload and diabetes risk: a shift from glucose to Fatty Acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes 2011; 60(1):80-7.
Utzschenneider, KM, Kowdley KV. Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol. 2010 ;6(1):26-33.
Gillum RF. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American menâ€”the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord 2001; 25:639â€“645.
Vari IS, Balkau B, Kettaneh A, Andre P, Tichet J, Fumeron F, et al. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007; 30:1795â€“1801.
Salonen JT, Tuomainen TP, NyyssÃ¶nen K, Lakka HM, Punnonen K. Relation between iron stores and non-insulin-dependent diabetes in men: case-control study. Br Med J 1999; 317:727â€“730.
Barbieri M, Ragno E, Benvenutti E, Zito GA, Corsi A, Ferrucci L. New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 2001; 44:1232â€“1237.
Lao TTCP, Tam KF: Gestational diabetes mellitus in the last trimester: a feature of maternal iron excess? Diabet Med 2001; 18:218â€“223.
Iwasaki T, Nakajima A, Yoneda M, Yamada Y, Mukasa K, Fujita K, et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 2005; 28:2486-91.
Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem 2005; 51:1201-5.
Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001; 103:52-7.
Ellervik C, Mandrup-Poulsen T, Andersen HU, TybjÃ¦rg-Hansen A, Frandsen M, et al. Elevated transferrin saturation and risk of diabetes: three population-based studies. Diabetes Care 2011; 34(10): 2256â€“8.
Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes 2014-2015. SÃ£o Paulo: AC FarmacÃªutica; 2015.
Sociedade Brasileira de Cardiologia. IV Diretriz Brasileira sobre Dislipidemias e PrevenÃ§Ã£o da Aterosclerose. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2007;88 Suppl I:2-19.
Oliveira EP, Souza MLA, Lima MDA. Ãndice HOMA (homeostasis model assessment) na prÃ¡tica clÃnica: uma revisÃ£o. J. Bras. Patol. Med. Lab. 2005; 41(4): 237-243.
HÃ¤mÃ¤lÃ¤inen P, Saltevo J, Kautiainen H, MÃ¤ntyselkÃ¤ P, Vanhala M. Erythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study. Cardiovascular Diabetology, 2012; 11:116.
Park SK, Ryoo JH, Kim MG, Shin JY. Association of Serum Ferritin and the Development of Metabolic Syndrome in Middle-Aged Korean Men A 5-year follow-up study. Diabetes Care 2012; 35(12): 2521-2526.
Kang HT, Linton JA, Shim JY. Serum ferritin level is associated with the prevalence of metabolic syndrome in Korean adults: the 2007â€“2008 Korean National Health and Nutrition Examination Survey. Clin Chim Acta 2012, 413(5â€“6):636â€“641.
Lecube A, Hernandez C, Pelegri D, Simo R. Factors accounting for high ferritin levels in obesity. Int J Obes (Lond) 2008, 32(11):1665â€“1669.
Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H, et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab 2008, 93(12): 4690â€“4696.
20.Bozzini C, Girelli D, Olivieri O, Martinelli N, Bassi A, De Matteis G, et al. . Prevalence of body iron excess in the metabolic syndrome. Diabetes Care 2005, 28(8):2061â€“2063.
Bao W, Rong Y, Rong S, Liu L. Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis. BMC Med.2012; 10:119.
Houschyar KS, LÃ¼dtke R, Dobos GJ, Kalus U, Broecker-Preuss M, Rampp T, et al. Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial. BMC Med. 2012; 10:54.
Jung CH, Lee MJ, Hwang JY, Jang JE, Leem J, et al. Elevated serum ferritin level is associated with the incident type 2 diabetes in healthy Korean men: a 4 year longitudinal study. PLoS One 2013; 8:75250.
Gelaye B, Revilla L, Lopez T, Suarez L, Sanchez SE, Hevner K. Association between insulin resistance and C-reactive protein among Peruvian adults. Diabetol. Metab. Syndr. 2010; 2:30.
Shankar A, Li J. Positive association between high-sensitivity C-reactive protein level and diabetes mellitus among US non-Hispanic black adults. Exp. Clin. Endocrinol. Diabetes 2008; 116:455â€“460.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aÂ Creative Commons Attribution LicenseÂ that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open AccessÂ and Benefits of Publishing Open Access).